www.fdanews.com/articles/134452-eu-drugs-body-restricts-bms-8217-s-hiv-drug-zerit
EU Drugs Body Restricts BMS’s HIV Drug Zerit
February 18, 2011
The European Union Drugs Agency says due to side effects with zerit from Bristol Myers Squibb, therapeutic indications should be restricted.
CNBC
CNBC